TREA

79415062 - ACELLYTRON THERAPEUTICS

Follow

Information

  • Trademark
  • 79415062
  • Serial Number
    79415062
  • Filing Date
    June 03, 2024
    a year ago
  • Transaction Date
    June 03, 2025
    4 months ago
  • Status Date
    June 03, 2025
    4 months ago
  • Published for Opposition Date
    June 03, 2025
    4 months ago
  • Location Date
    May 14, 2025
    5 months ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DIGAN, MATTHEW
  • Attorney Docket Number
    0904-0266US1
    Attorney Name
    Michael T. Smith
    Law Office Assigned Location Code
    N60
  • Owners
Information
Mark Drawing Code
3
Mark Identification
ACELLYTRON THERAPEUTICS
Case File Statements
  • DM0000: The mark consists of the wording "ACELLYTRON THERAPEUTICS" in a blue font with the "O" appearing in a slightly larger font and stylized with the design of a DNA helix and water drop.
  • GS0051: Chemical-pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; biochemical medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for medical purposes, namely, medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely, biological preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; medical cell inhibitor for inhibiting the growth of cancer cells; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely, tumor suppressors; cells for medical use; dietetic infusions, sugar, foods, and beverage substances adapted for medical use; biological preparations for veterinary purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer
  • CC0000: The color blue is claimed as a feature of the mark.
  • GS0351: Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing services; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
  • GS0441: Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance
  • DS0000: "THERAPEUTICS"
  • GS0421: Research and development of new products for others; technological research in the field of chemical and biological medicaments; chemical analysis; biochemical research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research; computer programming in the field of medical aspects
Case File Event Statements
  • 1/23/2025 - 9 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 1/29/2025 - 8 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/29/2025 - 8 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/30/2025 - 8 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/2/2025 - 8 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/12/2025 - 7 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/12/2025 - 7 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/29/2025 - 7 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/23/2025 - 6 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/23/2025 - 6 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/3/2025 - 8 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/23/2025 - 6 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/5/2025 - 5 months ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/5/2025 - 5 months ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/5/2025 - 5 months ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/5/2025 - 5 months ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/5/2025 - 5 months ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/28/2025 - 5 months ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/3/2025 - 4 months ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/3/2025 - 4 months ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB